Showing results (3031-3040 of 5,590) with videos related to
Sort By:
Pageof 559
Theranostics|May 1, 2019
Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their In Vivo T1 Contrast EfficacyYuqing Miao, Qian Xie, Huan Zhang, et al.Theranostics|May 1, 2019
Therapeutic Targeting of BRD4 in Head Neck Squamous Cell CarcinomaYaping Wu, Yanling Wang, Pengfei Diao, et al.Theranostics|May 1, 2019
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to TherapeuticsXiaojun Feng, Antoni Sureda, Samineh Jafari, et al.Theranostics|May 1, 2019
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and MetastasisXiao-Peng Tian, Chen-Yuan Wang, Xiao-Han Jin, et al.Theranostics|May 1, 2019
Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in MiceLunzhi Yuan, Yali Zhang, Xuan Liu, et al.Theranostics|July 21, 2018
Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal routeXiaofei Xin, Chao Teng, Xiaoqing Du, et al.Theranostics|July 21, 2018
A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancerPengfei Jiang, Lude Wang, Bailong Hou, et al.Theranostics|July 21, 2018
Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/β-catenin pathway in hepatocellular carcinomaJunwei Song, Chan Xie, Lili Jiang, et al.Theranostics|August 8, 2018
Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular CarcinomaDong-Yan Zhang, Xue-Jing Zou, Chuan-Hui Cao, et al.Theranostics|August 8, 2018
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranosticsXiao Zheng, Fan Zhang, Yawei Zhao, et al.Pageof 559